Oncolytic HSV1716 attenuates tumor-killing activity of infected primary NK cells

Katharina H. Susek, Dani Holla, Claire Marsal, Muhammad Kashif, Jonathan Albert, Viktoria Flore, Mari Gilljam, Maria Karvouni, Stephan Meinke, Arnika K. Wagner, Colin Powers, Robert Allen, Evren Alici

Open source

DOI: 10.3389/fimmu.2026.1895832
Published: 2026-08-03
Container: Frontiers in Immunology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1895832,
  title = {Oncolytic HSV1716 attenuates tumor-killing activity of infected primary NK cells},
  author = {Katharina H. Susek and Dani Holla and Claire Marsal and Muhammad Kashif and Jonathan Albert and Viktoria Flore and Mari Gilljam and Maria Karvouni and Stephan Meinke and Arnika K. Wagner and Colin Powers and Robert Allen and Evren Alici},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1895832},
  url = {https://doi.org/10.3389/fimmu.2026.1895832}
}

RIS

TY  - JOUR
TI  - Oncolytic HSV1716 attenuates tumor-killing activity of infected primary NK cells
AU  - Katharina H. Susek
AU  - Dani Holla
AU  - Claire Marsal
AU  - Muhammad Kashif
AU  - Jonathan Albert
AU  - Viktoria Flore
AU  - Mari Gilljam
AU  - Maria Karvouni
AU  - Stephan Meinke
AU  - Arnika K. Wagner
AU  - Colin Powers
AU  - Robert Allen
AU  - Evren Alici
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1895832
UR  - https://doi.org/10.3389/fimmu.2026.1895832
ER  -

APA

Susek, K. H., Holla, D., Marsal, C., Kashif, M., Albert, J., Flore, V., Gilljam, M., Karvouni, M., Meinke, S., Wagner, A. K., Powers, C., Allen, R., & Alici, E. (2026). Oncolytic HSV1716 attenuates tumor-killing activity of infected primary NK cells. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1895832

Source records

crossref · retrieved 2026-09-27T01:14:35.916Z